
New Biomarker Pre-Screening Platform Delivers
Biomarker Positive, Trial-Ready Patients
SplashBIO™ is a new scalable biomarker platform for clinical trials for early biomarker, genetic, and cognitive testing. SplashBIO™ provides precise diagnostic, prognostic, and predictive data to ensure that potential patients are biomarker positive and trial-ready – all before their first site visit!
Here’s how SplashBIO™ can benefit your next trial:
- Reduced Screen Failure Rates & Saved Money
- Accelerated Enrollment
- Improved Patient Experience